US Patent

US12059423 — Meloxicam composition, pharmaceutical preparation and preparation method and use thereof

Composition of Matter · Assigned to Nanjing Delova Biotech Co Ltd · Expires 2040-07-19 · 14y remaining

Vulnerability score 5/100 Ironclad — strong claim type, well-established, deep family

What this patent protects

This patent protects meloxicam compositions, pharmaceutical preparations, and preparation methods that enhance the solubility and stability of meloxicam.

USPTO Abstract

The disclosure is related to a meloxicam compositions, pharmaceutical preparations, preparation methods and use thereof. In one aspect of the invention, meloxicam compositions contain meloxicam and cosolvents. The cosolvents are mixed solvents including water and organic solvents. In another aspect of the invention, other compositions contain meloxicam, solvents, and pH regulators. The pH regulators include at least citric acid. The pharmaceutical compositions significantly enhance the solubility of meloxicam in liquid pharmaceutical preparations as well as stability. The meloxicam compositions can be directly used for intravenous injection administration to quickly reach effective therapeutic concentrations for post-operative analgesia.

Drugs covered by this patent

Patent Metadata

Patent number
US12059423
Jurisdiction
US
Classification
Composition of Matter
Expires
2040-07-19
Drug substance claim
Yes
Drug product claim
Yes
Assignee
Nanjing Delova Biotech Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.